Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $110.54. The company's market cap stands at 274.29B, with a P/E ratio of 14.62 and a dividend yield of 3.0%.
As of 2026-01-11, Merck(MRK) stock has fluctuated between $110.13 and $112.48. The current price stands at $110.54, placing the stock +0.4% above today's low and -1.7% off the high.
The Merck(MRK)'s current trading volume is 11.04M, compared to an average daily volume of 11.64M.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
MRK News
Schwab US Dividend Equity ETF ( $SCHD ) has risen by 1.83% in the past week. It has experienced a 5-day net inflow of $70.23 million. This is due, in part, to...
The company might become the latest biotech acquisition story soon. More often than not, takeover speculation can give a lively boost -- at least in the short...
Merck (MRK) is in talks to purchase Revolution Medicines (RVBD) for about $30 billion. Shares of Revolution Medicines jumped 11%. A deal for the cancer-drug bi...
Analyst ratings
57%
of 28 ratingsMore MRK News
Merck (MRK) is in talks to acquire Revolution Medicines (RVMD) in a deal that could value it at around $30B as the pharma giant has been discussing a deal value...
Revolution Medicines CEO Mark Goldsmith in 2020. Mark Kauzlarich/Bloomberg News Merck MRK 0.20 %increase; green up pointing triangle is in talks to acquire Rev...
Shares of biotech Revolution Medicines (RVMD) rallied more than 13% in Friday’s pre-market trading, after rising 4.6% yesterday in reaction to news of a potenti...
Biotech and Pharma Revolution Medicines Stock Soars. Takeover Buzz Grows, Another Suitor Emerges. In this article RVMD MRK ABBV Revolution Medicines stock was h...
Pharmaceuticals giant Merck & Co. Inc. (NYSE:MRK) is reportedly in talks to acquire cancer drug-maker Revolution Medicines Inc. (NASDAQ:RVMD) in a deal potentia...
If you are wondering whether Merck is fairly priced or offering value right now, it helps to step back and look at what the recent share performance and fundame...
15:44 EST Erasca (ERAS) jumps 22% after report on Merck (MRK) talks for rival Revolution Published first on TheFly – the ultimate source for real-time, market-...